JMJD2D anticorps (AA 337-499) (Biotin)

N° du produit ABIN7158705

L’anticorps Lapin Polyclonal anti-JMJD2D a été validé pour ELISA. Il convient pour détecter JMJD2D dans des échantillons de Humain.

Aperçu rapide pour JMJD2D anticorps (AA 337-499) (Biotin) (ABIN7158705)

Antigène: JMJD2D (KDM4D) (Lysine (K)-Specific Demethylase 4D (KDM4D))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp JMJD2D est conjugé à/à la Biotin

Application: ELISA

Détail du produit anti-JMJD2D anticorps (Biotin)

Épitope: AA 337-499

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Lysine-specific demethylase 4D protein (337-499AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur JMJD2D

Antigène: JMJD2D (KDM4D) (Lysine (K)-Specific Demethylase 4D (KDM4D))

Autre désignation: KDM4D

Sujet:

Background: Histone demethylase that specifically demethylates \'Lys-9\' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 \'Lys-4\', H3 \'Lys-27\', H3 \'Lys-36\' nor H4 \'Lys-20\'. Demethylates both di- and trimethylated H3 \'Lys-9\' residue, while it has no activity on monomethylated residues. Demethylation of Lys residue generates formaldehyde and succinate.

Aliases: JHD3D antibody, JHDM3D antibody, JmjC domain-containing histone demethylation protein 3D antibody, Jumonji domain-containing protein 2D antibody, Kdm4d antibody, KDM4D_HUMAN antibody, Lysine-specific demethylase 4D antibody

UniProt: Q6B0I6

Pathways: L'effet Warburg